These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 8449468
1. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation]. Henker J, Hoffmann D, Paul D, Hein J, Paditz E. Fortschr Med; 1993 Feb 10; 111(4):53-6. PubMed ID: 8449468 [Abstract] [Full Text] [Related]
2. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages. Ansaldi-Balocco N, Santini B, Sarchi C. J Pediatr Gastroenterol Nutr; 1988 Feb 10; 7 Suppl 1():S40-5. PubMed ID: 3042938 [Abstract] [Full Text] [Related]
3. A comparison of two pancreatin microsphere preparations in cystic fibrosis. Elliott RB, Escobar LC, Lees HR, Akroyd RM, Reilly HC. N Z Med J; 1992 Mar 25; 105(930):107-8. PubMed ID: 1553114 [Abstract] [Full Text] [Related]
4. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis]. Zsíros J, Sólyom E. Orv Hetil; 1988 May 08; 129(19):995-9. PubMed ID: 3290773 [No Abstract] [Full Text] [Related]
6. [Pancreatic enzyme substitution in patients with mucoviscidosis]. Henker J. Gastroenterol J; 1990 Nov 02; 49(4):151-5. PubMed ID: 2184824 [Abstract] [Full Text] [Related]
7. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis. Mitchell EA, Quested C, Marks RE, Pinnock RE, Elliott RB. Aust Paediatr J; 1982 Jun 02; 18(2):114-7. PubMed ID: 6923744 [No Abstract] [Full Text] [Related]
8. [Pancreatic enzyme replacement in mucoviscidosis (CF): clinical evaluation of a gastric acid-resistant pancreatin preparation in encapsulated microtablet form]. Stern M, Plettner C, Grüttner R. Klin Padiatr; 1988 Jun 02; 200(1):36-9. PubMed ID: 2452915 [Abstract] [Full Text] [Related]
9. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)]. Gottschalk B, Wiesemann HG, Stephan U. Monatsschr Kinderheilkd; 1988 Sep 02; 136(9):626-9. PubMed ID: 3237230 [Abstract] [Full Text] [Related]
10. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin]. Aparisi L, Rodrigo JM, Serra MA, Del Olmo J, Bisquert M, Raga F. Rev Esp Enferm Apar Dig; 1989 Jul 02; 76(1):25-30. PubMed ID: 2799034 [Abstract] [Full Text] [Related]
11. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy. Braden B, Picard H, Caspary WF, Posselt HG, Lembcke B. Z Gastroenterol; 1997 Feb 02; 35(2):123-9. PubMed ID: 9066102 [Abstract] [Full Text] [Related]
12. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Dutta SK, Rubin J, Harvey J. Gastroenterology; 1983 Mar 02; 84(3):476-82. PubMed ID: 6549746 [Abstract] [Full Text] [Related]